<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01843101</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-040413</org_study_id>
    <nct_id>NCT01843101</nct_id>
  </id_info>
  <brief_title>Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study</brief_title>
  <official_title>Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to develop a protocol for optimal corneal 3-dimensional
      imaging based on measurements in healthy volunteers. For this purpose, a customized
      ultra-high resolution Spectral Domain OCT will be used. To validate whether the protocol can
      also be applied in patients with corneal pathologies, for whom it is intended to be used,
      measurements in these patients will be performed. We propose to obtain images from patients
      with keratoconus, since this is one of the most frequent causes for corneal transplantations
      in Europe and from patients with corneal neovascularization which is a major cause of vision
      loss in several ophthalmic diseases. Based on the obtained measurement protocol, further
      studies investigating the pathophysiology or treatment success of several corneal pathologies
      can be planned.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2014</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Imaging</measure>
    <time_frame>1 day</time_frame>
    <description>Development of a measurement protocol for 3 dimensional imaging of the human cornea</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Imaging of corneal pathologies</measure>
    <time_frame>1 day</time_frame>
    <description>Application of the protocol in patients with corneal pathologies</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Corneal Neovascularisation</condition>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>10 healthy volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corneal Neovascularisation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>5 patients with corneal neovascularisation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Keratoconus</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>5 patients with keratoconus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>Imaging of the cornea using ultrahigh resolution Spectral Domain OCT</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Corneal Neovascularisation</arm_group_label>
    <arm_group_label>Keratoconus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy volunteers:

          -  Men and women aged over 18 years

          -  Normal findings in the slit lamp examination, no corneal pathologies

        Patients with keratoconus:

          -  Men and women aged over 18 years

          -  Presence of keratoconus

          -  No ophthalmic surgery in the 3 months preceding the study

        Patients with corneal neovascularization:

          -  Men and women aged over 18 years

          -  Presence of corneal neovascularization

          -  No ophthalmic surgery in the 3 months preceding the study

        Exclusion Criteria:

          -  Participation in a clinical trial in the previous 3 weeks

          -  Presence of any abnormalities preventing reliable measurements as judged by the
             investigator

          -  Pregnancy, planned pregnancy or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katarzyna Napora, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacology, Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerhard Garhoefer, MD</last_name>
    <phone>+43 1 40400</phone>
    <phone_ext>2981</phone_ext>
    <email>gerhard.garhoefer@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Clinical Pharmacology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Garhoefer, MD</last_name>
      <phone>+43 1 40400</phone>
      <phone_ext>2981</phone_ext>
      <email>gerhard.garhoefer@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Katarzyna Napora, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2013</study_first_submitted>
  <study_first_submitted_qc>April 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2013</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Garhofer</investigator_full_name>
    <investigator_title>Assoc. Prof. PD Dr.</investigator_title>
  </responsible_party>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>Cornea</keyword>
  <keyword>Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neovascularization, Pathologic</mesh_term>
    <mesh_term>Keratoconus</mesh_term>
    <mesh_term>Corneal Neovascularization</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

